I'm not sure how much impact this conference will have - they are presenting animal models ie. preclinical data.
Currently, the upcoming ACV1 announcement relates to Phase II trials, which is years ahead of animal models..
That said, even if they present it at the same time during a trading halt, it will definitely aid the SP.
Add to My Watchlist
What is My Watchlist?